In contrast to prior findings suggesting that miR-144/miR-451a inhibit HCC cell proliferation by targeting oncogenes such as EZH2, the abovementioned study revealed their predominant tumor-suppressive role in reshaping the tumor immune microenvironment. The gene discussed is EZH2; the disease is hepatocellular carcinoma.